AML
Anti-Money Laundering (AML) is a regulatory framework established by the international community to combat illicit financial flows. It requires financial institutions to identify, monitor and report suspicious transactions in order to prevent criminal proceeds from being legitimized.
Timeline (last 90 days)
全球大多数持牌支付机构都被要求执行KYC（了解你的客户）流程，通过收集和验证用户的身份信息来确认客户真实身份。
账户一旦被转手，原有的KYC记录即与实际操作者脱节，这不仅违反平台协议，也可能触犯所在地的反洗钱法规。
KYC and AML are often mandated by regulators, and the rules are adjusted as policies are updated.
AML (Anti-Money Laundering) is a set of ongoing compliance mechanisms covering transaction monitoring, identification of suspicious behavior, and large-value and suspicious transaction reporting.
KYC is a core component of the anti-money laundering (AML) and counter-terrorist financing (CFT) legal framework, and is the first line of defense of the AML/CFT system.
Under sanctions frameworks, assisting a sanctioned individual in transferring assets or evading reporting obligations may violate anti-money laundering regulations, OFAC sanctions rules, and tax laws across various jurisdictions.
KYC (Know Your Customer) is a mandatory compliance requirement in the financial regulatory domain, originating from the Anti-Money Laundering (AML) and Counter-Terrorist Financing (CFT) regulatory framework.
Electronic signature laws, payment compliance requirements (such as KYC/AML), and phone real-name registration systems in most countries and regions presuppose that users are natural persons or legal entities, and the legality of AI agents registering or making payments under an independent identity has not yet been clearly adjudicated.
Addressing cryptocurrency crime requires pushing exchanges to implement stricter Know Your Customer (KYC) and Anti-Money Laundering (AML) measures.
Complete remission (CR) in AML typically refers to a reduction in the proportion of blast cells in the bone marrow to below 5%, recovery of normal peripheral blood cell counts, and no evidence of extramedullary leukemia, but remission does not equal cure.
5 more timeline events
All Facts (15)
Merchant onboarding is a standard compliance process in the payment industry, typically involving identity verification (KYC/KYB), business risk assessment, anti-money laundering (AML) checks, and credit risk evaluation
90%Unverified账户一旦被转手，原有的KYC记录即与实际操作者脱节，这不仅违反平台协议，也可能触犯所在地的反洗钱法规。
50%Unverified全球大多数持牌支付机构都被要求执行KYC（了解你的客户）流程，通过收集和验证用户的身份信息来确认客户真实身份。
50%UnverifiedAML (Anti-Money Laundering) is a set of ongoing compliance mechanisms covering transaction monitoring, identification of suspicious behavior, and large-value and suspicious transaction reporting.
50%UnverifiedKYC and AML are often mandated by regulators, and the rules are adjusted as policies are updated.
50%UnverifiedKYC is a core component of the anti-money laundering (AML) and counter-terrorist financing (CFT) legal framework, and is the first line of defense of the AML/CFT system.
50%UnverifiedUnder sanctions frameworks, assisting a sanctioned individual in transferring assets or evading reporting obligations may violate anti-money laundering regulations, OFAC sanctions rules, and tax laws across various jurisdictions.
50%UnverifiedKYC (Know Your Customer) is a mandatory compliance requirement in the financial regulatory domain, originating from the Anti-Money Laundering (AML) and Counter-Terrorist Financing (CFT) regulatory framework.
50%UnverifiedElectronic signature laws, payment compliance requirements (such as KYC/AML), and phone real-name registration systems in most countries and regions presuppose that users are natural persons or legal entities, and the legality of AI agents registering or making payments under an independent identity has not yet been clearly adjudicated.
50%UnverifiedAddressing cryptocurrency crime requires pushing exchanges to implement stricter Know Your Customer (KYC) and Anti-Money Laundering (AML) measures.
50%UnverifiedThe 2022 updated WHO classification and International Consensus Classification (ICC) subdivide AML into multiple molecular subtypes for risk stratification based on specific gene mutations (such as FLT3-ITD, NPM1, CEBPA, and TP53) and chromosomal abnormalities.
50%UnverifiedAML patients carrying FLT3 mutations can be treated with the targeted drugs midostaurin or gilteritinib, while patients with IDH1/2 mutations can use ivosidenib or enasidenib.
50%UnverifiedComplete remission (CR) in AML typically refers to a reduction in the proportion of blast cells in the bone marrow to below 5%, recovery of normal peripheral blood cell counts, and no evidence of extramedullary leukemia, but remission does not equal cure.
50%UnverifiedAcute myeloid leukemia (AML) is a malignant clonal disease originating from bone marrow hematopoietic stem cells, with a median diagnosis age of approximately 68 years and a five-year overall survival rate of approximately 30%.
50%UnverifiedIf left untreated, AML can become life-threatening within weeks to months; for patients who are diagnosed early and receive systematic treatment, the complete remission rate for certain subtypes can reach 60%–80%.
50%